Atlas FDA

JUVEDERM HYALURONATE GEL IMPLANTS

FDA premarket approval P050047/S020 · decided 2012-01-20

Approval details

PMA number
P050047
Supplement
S020
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
JUVEDERM HYALURONATE GEL IMPLANTS
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2011-09-26
Decision date
2012-01-20
Days to decision
116 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
APPROVAL FOR AN EXTENSION OF THE SHELF LIFE FROM 12 MONTHS TO 18 MONTHS FOR THE 1.0ML SYRINGE; AN INCREASE IN THE MONOETHYLGLYCIN-EXYLIDIDE (MEGX) IMPURITY SPECIFICATION FROM <=3% W/W OF LABEL STRENGTH TO <=2.5% W/W OF LABEL STRENGTH; AND AN INCREASE IN INDIVIDUAL UNIDENTIFIED IMPURITIES SPECIFICATIONS FROM <=0.1% W/W OF LABEL STRENGTH TO<=0.2% W/W OF LABEL STRENGTH.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25